/
Other
Vaccine
37
Pipeline Programs↗
36
Active Trials↗
40
Companies Involved↗
Vaccine is a moderately active landscape with 37 programs across 40 companies. The most active players are Sanofi, Pfizer, Moderna. 12 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 112
Phase 27
Approved
No programs
Analysis
Modality Breakdown
74%
Vaccine
14 of 19 classified programs — the dominant modality here.
Vaccine leads; the ring shows all 19 classified programs, each share of the total. Modality classified for 100% of 37 pipeline programs.
Analysis
Trial Status
518
clinical trials
Completed407 · 79%
Unknown status40 · 8%
Terminated22 · 4%
Recruiting18 · 3%
Active, not recruiting14 · 3%
Withdrawn12 · 2%
Other5 · 1%
Clinical Trials
Trial Activity
518 trials
Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya
Recruiting·—·Phase 4·NCT07487077·1,071 enrolled
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Recruiting·—·Phase 2·NCT07199569·744 enrolled
Page 1 of 35
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)